Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Yulia Hirschberg"'
Autor:
María Luz Ruiz-Falcó Rojas, Martha Feucht, Alfons Macaya, Bernd Wilken, Andreas Hahn, Ricardo Maamari, Yulia Hirschberg, Antonia Ridolfi, John Chris Kingswood
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
The TuberOus SClerosis registry to increase disease Awareness (TOSCA) Post-Authorization Safety Study (PASS) was a non-interventional, multicenter, safety substudy that assessed the long-term safety of everolimus in patients with tuberous sclerosis c
Externí odkaz:
https://doaj.org/article/d7a5927dfb6849c78b7004917ea2fba5
Autor:
Eric Jonasch, Luca Dezzani, Chaitali Babanrao Pisal, Angel Rodriguez Sanchez, Yulia Hirschberg, Giuseppe Procopio, Haralabos P. Kalofonos, Narayanan Srihari, Manuela Schmidinger, Cristina Suarez Rodriguez, Qasim Ahmad, Aristotelis Bamias, Sergio Vázquez Estevez, Petri Bono, Robert E. Hawkins
Patients with intermediate-risk advanced renal cell carcinoma are a heterogeneous population, having either 1 or 2 risk factors. It is unclear whether all patients in this risk category should be treated similarly. A secondary analysis of the PRINCIP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b57f3a70bfd6fbe312985080127fd42d
http://hdl.handle.net/10138/318789
http://hdl.handle.net/10138/318789
Autor:
Bohuslav Melichar, Thomas Powles, R. Tyagi, A. Gaur, Yulia Hirschberg, Mauricio Burotto, M.D. Michaelson, Emiliano Calvo, Viktor Grünwald, Stéphane Oudard, Daniel Y. Heng, F. Hilmi
Publikováno v:
Annals of Oncology. 31:S564
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9164e4ba3e69b030bd29f0e28ad4ccef
https://doi.org/10.1016/j.annonc.2020.08.790
https://doi.org/10.1016/j.annonc.2020.08.790
Autor:
Tae Min Kim, Sun Young Rha, Barnali Pramanik, Sith Sathornsumetee, Barbara D Wamil, Federico Longo, Victor Moreno, Shirong Zhang, Yulia Hirschberg, Igor Kiss
Publikováno v:
Journal of Clinical Oncology. 38:3520-3520
3520 Background: Prior studies have confirmed the efficacy and safety of ceritinib in patients (pts) with advanced ALK+ non-small cell lung cancer (Soria, et al, Lancet 2017; Shaw et al, Lancet Oncol 2017; Cho et al, JTO 2019). Ceritinib also demonst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58daa85438181d1b5f20cf65b488e16c
https://doi.org/10.1200/jco.2020.38.15_suppl.3520
https://doi.org/10.1200/jco.2020.38.15_suppl.3520
Autor:
L. Dezzani, D. Michaelson, Yulia Hirschberg, Viktor Grünwald, Stéphane Oudard, Thomas Powles, Emiliano Calvo, S. Acharya, D.Y.C. Heng
Publikováno v:
European Urology Supplements. 17:e2957
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51d77c33dd146d2116bf4941af2f2548
https://doi.org/10.1016/s1569-9056(18)33804-1
https://doi.org/10.1016/s1569-9056(18)33804-1
Autor:
Robert E. Hawkins, Yulia Hirschberg, Qasim Ahmad, Chaitali Babanrao Pisal, C. Suarez Rodriguez, Petri Bono, Luca Dezzani, Á. Rodríguez Sánchez, Aristotle Bamias, Eric Jonasch, Narayanan Srihari, Saulo A. Vázquez, Manuela Schmidinger, Giuseppe Procopio, H. P. Kalofonos
Publikováno v:
Annals of Oncology. 29:viii313
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0357f6f64a012953153c88c9c0d0a0a8
https://doi.org/10.1093/annonc/mdy283.093
https://doi.org/10.1093/annonc/mdy283.093
Autor:
Manuela Schmidinger, Chaitali Babanrao Pisal, Giuseppe Procopio, Eric Jonasch, Luca Dezzani, Haralabos P. Kalofonos, Yulia Hirschberg, Sergio Vázquez, Robert E. Hawkins, Angel Sánchez, Aristotelis Bamias, Petri Bono, Narayanan Srihari, Qasim Ahmad
Publikováno v:
Journal of Clinical Oncology. 36:4574-4574
4574Background: PRINCIPAL (NCT01649778) was the largest prospective real-world effectiveness and safety study of pazopanib (PAZ) in patients (pts) with renal cell carcinoma (RCC). Methods: Pts with...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e00a491fecaa2e19134580d0b2ab8a28
https://doi.org/10.1200/jco.2018.36.15_suppl.4574
https://doi.org/10.1200/jco.2018.36.15_suppl.4574
Autor:
Aristotelis Bamias, Petri Bono, Giuseppe Procopio, Chaitali Babanrao Pisal, Qasim I. Ahmad, Narayanan Srihari, Angel Sánchez, Manuela Schmidinger, Haralabos P. Kalofonos, Eric Jonasch, Yulia Hirschberg, Luca Dezzani, Sergio Vázquez, Robert E. Hawkins
Publikováno v:
Journal of Clinical Oncology. 36:4561-4561
4561Background: Although pazopanib (PAZ) has been evaluated in clinical trials of patients (pts) with renal cell carcinoma (RCC), limited real-world data on the effectiveness and safety of PAZ exis...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24e25a6a89a548fb1234ad6162864f84
https://doi.org/10.1200/jco.2018.36.15_suppl.4561
https://doi.org/10.1200/jco.2018.36.15_suppl.4561
Publikováno v:
The Journal of Clinical Pharmacology. 40:634-640
This single-dose, open-label, parallel-group study compared the pharmacokinetics and tolerability of 120 mg doses of nateglinide, a physiologic mealtime glucose regulator for type 2 diabetes, in 8 subjects with cirrhosis and 8 matched healthy subject
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cefb13a513da8212e374b0c50f11cb3
https://doi.org/10.1002/j.1552-4604.2000.tb05989.x
https://doi.org/10.1002/j.1552-4604.2000.tb05989.x
Autor:
Yulia Hirschberg, Nicholas Lowther, Yi Jin, Hanspeter Nick, Roy Fox, Harry Donnelly, Rebecca L. Oberle, Thomas Sergejew, Bernard Faller
Publikováno v:
Pharmaceutical Research. 16:434-440
Purpose. The in vitro and in situ transport of CGP 65015 ((+)-3-hydroxy-1-(2-hydroxyethyl) -2-hydroxyphenyl-methyl-1 H-pyridin-4-one), a novel oral iron chelator, is described. The predictive power of these data in assessing intestinal absorption in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c2de4c1ffa3ccba92be72a0148e8397
https://doi.org/10.1023/a:1018886005136
https://doi.org/10.1023/a:1018886005136